Abiopharma

Collard Craig A 🟡 adjusted position in 0 shares (1 derivative) of HERON THERAPEUTICS, INC. /DE/ (HRTX) Transaction Date: Jan 19, 2026 | Filing ID: 016413

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)

Agilon Health Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL

New Form SCHEDULE 13G - InMed Pharmaceuticals Inc. Filed: 2026-01-20 AccNo: 0001535610-26-000009 Size: 9 KB

Ways to Use NotebookLM: Practical Ideas and Real‑World Use Cases

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Exicure HiTron Inc. 🔴 sold 734.7K shares of EXICURE, INC. (XCUR) at $4.50 ($3.3M) Transaction Date: Jan 16, 2026 | Filing ID: 000004

PULSENMORE (PLSM) was added to the list of traded instruments on TASE exchange

HRT FINANCIAL LP 🟡 adjusted position in 21.2K shares of AKANDA CORP. (AKAN) at $1.40 Transaction Date: Jan 15, 2025 | Filing ID: 000002

New Form SCHEDULE 13G - Biodexa Pharmaceuticals Plc Filed: 2026-01-20 AccNo: 0001535610-26-000008 Size: 9 KB